Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial

Medicine & Life Sciences

1. Receptor, Fibroblast Growth Factor, Type 2 100%
2. Cholangiocarcinoma 93%
3. Fibroblast Growth Factors 86%
4. Psychological Inhibition 57%
5. Clinical Trials 47%
6. Proteins 30%
7. Tyrosine 27%
8. src-Family Kinases 26%
9. Nuclear Proteins 22%
10. Heterografts 20%
11. Phosphorylation 15%
12. Preliminary Data 15%
13. Biomarkers 14%
14. Drive 13%
15. Therapeutics 12%
16. Patient Selection 12%
17. Biliary Tract Neoplasms 10%
18. Transcriptional Activation 5%
19. Cell Death 5%